Biosensors: Terumo, Biosensors extend licensing agreement to market and sell BioMatrix technology

Biosensors International Group, Ltd. and Terumo Corporation announced today an extension of their existing licensing agreements, under which Terumo may continue to incorporate BioMatrix technology in the production, marketing and selling of Terumo's drug-eluting stent (DES) systems in markets worldwide, outside of the United States.